These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6117649)

  • 21. Effects of eight-week treatment with histamine H2-antagonists or an antacid on plasma levels of histamine and serotonin in duodenal ulcer patients.
    Lai KH; Cho CH; Ogle CW; Wang JY
    Pharmacol Res Commun; 1986 Sep; 18(9):807-12. PubMed ID: 2432622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa.
    Ribet A; Balas D; Bastie MJ; Senegas-Balas F; Escourrou J; Bommelaer G; Pradayrol L
    Scand J Gastroenterol Suppl; 1981; 70():155-74. PubMed ID: 6118944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cimetidine and ranitidine in duodenal ulcer.
    Langman MJ; Henry DA; Bell GB; Burnham WR; Ogilvy A
    Br Med J; 1980 Aug; 281(6238):473-4. PubMed ID: 6107154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasma variations in prolactin half-way through treatment with H2-antagonists].
    Cataldo MG; Salvia A; Campisi D; Bivona A; Militello A; Rotolo G; Paterna S
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):531-8. PubMed ID: 4041255
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of ranitidine, a new histamine H 2-receptor antagonist, on the amylase/creatinine clearance ratio.
    Mohammed R; Mitchell K
    Br J Clin Pharmacol; 1981 Apr; 11(4):408. PubMed ID: 6167279
    [No Abstract]   [Full Text] [Related]  

  • 27. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ranitidine on pituitary hormone secretion in vitro.
    Yeo T; Delitala G; Besser GM; Edwards CR
    Br J Clin Pharmacol; 1980 Aug; 10(2):171-3. PubMed ID: 6107117
    [No Abstract]   [Full Text] [Related]  

  • 30. [New generation of histamine H2 receptor blockaders].
    Radbil' OS; Sukherova MI
    Sov Med; 1982; (12):80-5. PubMed ID: 6131545
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of histamine stimulation and H2 -receptor inhibition on the pituitary prolactin and ACTH release and on cortisol secretion in human males.
    Knigge U; Wollesen F; Dejgaard A; Larsen K; Christiansen PM
    Horm Metab Res; 1983; 15(2):89-91. PubMed ID: 6131028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].
    Bradshaw J; Brittain RT; Clitherow JW; Daly MJ; Jack D; Price BJ; Stables R
    Br J Pharmacol; 1979 Jul; 66(3):464P. PubMed ID: 43178
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine.
    Bertaccini G; Coruzzi G
    Agents Actions; 1982 Apr; 12(1-2):168-71. PubMed ID: 6123238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
    Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
    Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
    Londong W; Londong V; Ruthe C; Weizert P
    Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
    Hüttemann W
    Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.